Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;73(2):453-455.
doi: 10.1016/j.jhep.2020.04.002. Epub 2020 Apr 10.

Management of patients with autoimmune liver disease during COVID-19 pandemic

Ana Lleo  1 , Pietro Invernizzi  2 , Ansgar W Lohse  3 , Alessio Aghemo  4 , Marco Carbone  2
Affiliations

Management of patients with autoimmune liver disease during COVID-19 pandemic

Ana Lleo et al. J Hepatol. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest Please refer to the accompanying ICMJE disclosure forms for further details.

Figures

Fig. 1
Fig. 1
Management protocol for patients with autoimmune liver diseases during the COVID-19 pandemic. AIH, autoimmune hepatitis; AILD, autoimmune liver disease; COVID-19, coronavirus disease 2019; ER, emergency room; ERN, European reference network; GI, gastrointestinal; GP, general practitioner; PSC, primary sclerosing cholangitis.
See this image and copyright information in PMC

References

    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 - PMC - PubMed
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
    1. Zhang C., Shi L., Wang F.S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428–430. - PMC - PubMed
    1. Kirchgesner J., Lemaitre M., Carrat F., Zureik M., Carbonnel F., Dray-Spira R. Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases. Gastroenterology. 2018;155:337–346.e10. - PubMed
    1. Kaltsas A., Sepkowitz K. Community acquired respiratory and gastrointestinal viral infections: challenges in the immunocompromised host. Curr Opin Infect Dis. 2012;25:423–430. - PubMed

MeSH terms

Substances